Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.07% | 243.14 | 1.5% | $878.54m | |
| MRNA | Moderna, Inc. | 4.37% | 149.09 | 0.0% | $806.04m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.36% | 282.79 | 1.9% | $481.53m | |
| GILD | Gilead Sciences, Inc. | -0.14% | 61.72 | 1.0% | $474.71m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.17% | 590.14 | 2.6% | $470.87m | |
| NVAX | Novavax, Inc. | 9.89% | 56.52 | 75.7% | $437.96m | |
| ILMN | Illumina, Inc. | 2.25% | 188.50 | 3.3% | $343.40m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -6.19% | 3.64 | 0.7% | $254.45m | |
| BIIB | Biogen, Inc. | 1.21% | 206.40 | 1.8% | $240.94m | |
| BNTX | BioNTech SE | 4.60% | 155.96 | 0.0% | $195.77m | |
| CRSP | CRISPR Therapeutics AG | 2.51% | 62.30 | 0.6% | $164.12m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.85% | 83.58 | 4.2% | $117.18m | |
| EXAS | EXACT Sciences Corp. | 3.02% | 40.58 | 17.7% | $93.68m | |
| IOVA | Iovance Biotherapeutics, Inc. | 2.54% | 11.32 | 0.0% | $90.34m | |
| TECH | Bio-Techne Corp. | 0.19% | 347.28 | 4.5% | $89.78m |
Company Profile
Verve Therapeutics, Inc. is a genetic medicines company engaged in the development of a new approach to the care of cardiovascular disease. It aims to transform treatment from chronic management to single-course gene editing medicines. Its goal is to disrupt the chronic care model for CVD by providing a new therapeutic approach with single-course in vivo gene editing treatments focused on addressing the root causes of this highly prevalent and life-threatening disease. The company was founded by Sekar Kathiresan, Kiran Musunuru, Keith J. Joung, Issi Rozen, Sekar Kathiresan and Burt A. Adelman in 2018 and is headquartered in Cambridge, MA.